Reference number : 236-2014-2015-Q4-00256, amendment number : , agreement type : G, recipient legal name : SHEERAN, Paul S, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M4N 3M5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 140000.0, agreement start date : 2015-04-01, agreement end date : 2017-02-28, description english : Development of a new anti-cancer drug delivery platform using acoustically activated nanoscale and microscale agents, description french : Development of a new anti-cancer drug delivery platform using acoustically activated nanoscale and microscale agents, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2016-17)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2016-17)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada